These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30755239)

  • 1. Human bone marrow-derived mesenchymal stem cells promote the growth and drug-resistance of diffuse large B-cell lymphoma by secreting IL-6 and elevating IL-17A levels.
    Zhong W; Zhu Z; Xu X; Zhang H; Xiong H; Li Q; Wei Y
    J Exp Clin Cancer Res; 2019 Feb; 38(1):73. PubMed ID: 30755239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Th17 cells and IL-17A exist in patients with B cell acute lymphoblastic leukemia and promote proliferation and resistance to daunorubicin through activation of Akt signaling.
    Bi L; Wu J; Ye A; Wu J; Yu K; Zhang S; Han Y
    J Transl Med; 2016 May; 14(1):132. PubMed ID: 27176825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of tandem diabody (IL-6/CD20)-secreting human umbilical cord mesenchymal stem cells and its experimental treatment on diffuse large B cell lymphoma.
    Zhang J; Zhong M; Zhong W; Lan Y; Yuan Z; Duan Y; Wei Y
    Stem Cell Res Ther; 2022 Sep; 13(1):473. PubMed ID: 36104733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased interleukin-17A levels promote rituximab resistance by suppressing p53 expression and predict an unfavorable prognosis in patients with diffuse large B cell lymphoma.
    Zhong W; Xu X; Zhu Z; Yang L; Du H; Xia Z; Yuan Z; Xiong H; Du Q; Wei Y; Li Q
    Int J Oncol; 2018 May; 52(5):1528-1538. PubMed ID: 29512700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow-derived and synovium-derived mesenchymal cells promote Th17 cell expansion and activation through caspase 1 activation: contribution to the chronicity of rheumatoid arthritis.
    Eljaafari A; Tartelin ML; Aissaoui H; Chevrel G; Osta B; Lavocat F; Miossec P
    Arthritis Rheum; 2012 Jul; 64(7):2147-57. PubMed ID: 22275154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-9 promotes cell survival and drug resistance in diffuse large B-cell lymphoma.
    Lv X; Feng L; Ge X; Lu K; Wang X
    J Exp Clin Cancer Res; 2016 Jul; 35(1):106. PubMed ID: 27364124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3 activation is associated with cerebrospinal fluid interleukin-10 (IL-10) in primary central nervous system diffuse large B cell lymphoma.
    Mizowaki T; Sasayama T; Tanaka K; Mizukawa K; Takata K; Nakamizo S; Tanaka H; Nagashima H; Nishihara M; Hirose T; Itoh T; Kohmura E
    J Neurooncol; 2015 Sep; 124(2):165-74. PubMed ID: 26080800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients.
    Zhong W; Xu X; Zhu Z; Du Q; Du H; Yang L; Ling Y; Xiong H; Li Q
    Oncotarget; 2017 Jul; 8(30):49757-49772. PubMed ID: 28537908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ibrutinib inhibits mesenchymal stem cells-mediated drug resistance in diffuse large B-cell lymphoma].
    Wu L; Zhang YZ; Xia B; Li XW; Yuan T; Tian C; Zhao HF; Yu Y; Sotomayor E
    Zhonghua Xue Ye Xue Za Zhi; 2017 Dec; 38(12):1036-1042. PubMed ID: 29365396
    [No Abstract]   [Full Text] [Related]  

  • 10. Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab.
    Xu ZZ; Xia ZG; Wang AH; Wang WF; Liu ZY; Chen LY; Li JM
    Ann Hematol; 2013 Oct; 92(10):1351-8. PubMed ID: 23636313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIK3CD promoted proliferation in diffuse large B cell lymphoma through upregulation of c-myc.
    Cui W; Zheng S; Li X; Ma Y; Sang W; Liu M; Zhang W; Zhou X
    Tumour Biol; 2016 Sep; 37(9):12767-12777. PubMed ID: 27448819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospho-p70S6K/p85S6K and cdc2/cdk1 are novel targets for diffuse large B-cell lymphoma combination therapy.
    Zhao MY; Auerbach A; D'Costa AM; Rapoport AP; Burger AM; Sausville EA; Stass SA; Jiang F; Sands AM; Aguilera N; Zhao XF
    Clin Cancer Res; 2009 Mar; 15(5):1708-20. PubMed ID: 19223503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human colorectal cancer-derived mesenchymal stem cells promote colorectal cancer progression through IL-6/JAK2/STAT3 signaling.
    Zhang X; Hu F; Li G; Li G; Yang X; Liu L; Zhang R; Zhang B; Feng Y
    Cell Death Dis; 2018 Jan; 9(2):25. PubMed ID: 29348540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel silicone derivative of natural osalmid (DCZ0858) induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma via the JAK2/STAT3 pathway.
    Lu K; Li B; Zhang H; Xu Z; Song D; Gao L; Sun H; Li L; Wang Y; Feng Q; Chen G; Hu L; Wei R; Xie Y; Yu D; Wu X; Zhu W; Shi J
    Signal Transduct Target Ther; 2020 Apr; 5(1):31. PubMed ID: 32296013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
    Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
    Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17A promotes the invasion-metastasis cascade via the AKT pathway in hepatocellular carcinoma.
    Xu QG; Yu J; Guo XG; Hou GJ; Yuan SX; Yang Y; Yang Y; Liu H; Pan ZY; Yang F; Gu FM; Zhou WP
    Mol Oncol; 2018 Jun; 12(6):936-952. PubMed ID: 29689643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDGFD induces ibrutinib resistance of diffuse large B‑cell lymphoma through activation of EGFR.
    Jin J; Wang L; Tao Z; Zhang J; Lv F; Cao J; Hu X
    Mol Med Rep; 2020 May; 21(5):2209-2219. PubMed ID: 32186759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway.
    Bai M; Zhang L; Fu B; Bai J; Zhang Y; Cai G; Bai X; Feng Z; Sun S; Chen X
    Kidney Int; 2018 Apr; 93(4):814-825. PubMed ID: 29132705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of IL-17A responses in human airway smooth muscle cells by Oncostatin M.
    Kwofie K; Scott M; Rodrigues R; Guerette J; Radford K; Nair P; Richards CD
    Respir Res; 2015 Feb; 16(1):14. PubMed ID: 25849622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone Marrow Molecular Markers Associated with Relapsed/Refractory Activated B-Cell-Like Diffuse Large B-Cell Lymphoma.
    Wang D; Liu P; Zhang Y; Liu HY; Shen D; Che YQ
    Biomed Res Int; 2018; 2018():1042597. PubMed ID: 30534553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.